France’s state health institute, Inserm, is in talks with Guinea authorities on the first clinical trials of experimental Ebola therapies to be used on patients in the West African country.
Inserm is considering two trials, each involving at most 15 patients, to test compounds from Fujifilm Holdi
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Albertina Torsoli and Ougna Camara
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
